Dr. Daniel T. Lee, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) (1993)
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 707
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1993Medical school: University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb)
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
MI license 4301074550
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mymichigan Medical Center Midland Midland, MI
- Mclaren Bay Region Bay City, MI
- Mclaren Central Michigan Mount Pleasant, MI
- Tawas St Joseph Hospital Tawas City, MI
- Saint Mary's Standish Community Hospital Standish, MI
Medical groups
- Mclaren Medical Group (213 clinicians)
- Mclaren Central Michigan (182 clinicians)
- Mclaren Bay Region (113 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 707
- Services billed
- 1,794
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 293 | 237 |
| Established patient office or other outpatient visit, 30-39 minutes | 228 | 204 |
| Established patient office or other outpatient visit, 20-29 minutes | 214 | 187 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 166 | 166 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 134 | 54 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 125 | 124 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 46 | 45 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 42 | 42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 39 | 39 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 38 | 38 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Saginaw, MI | 707 |
| Rosuvastatin Calcium Other prescribers in Saginaw, MI | 663 |
| Xarelto (rivaroxaban) Other prescribers in Saginaw, MI | 453 |
| Repatha Sureclick (evolocumab) Other prescribers in Saginaw, MI | 305 |
| Metoprolol Tartrate Other prescribers in Saginaw, MI | 303 |
| Lisinopril Other prescribers in Saginaw, MI | 292 |
| Eliquis (apixaban) Other prescribers in Saginaw, MI | 263 |
| Amlodipine Besylate Other prescribers in Saginaw, MI | 230 |
| Metoprolol Succinate Other prescribers in Saginaw, MI | 214 |
| Furosemide Other prescribers in Saginaw, MI | 204 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 47 payments worth $16,524 in total to this clinician.
| Amgen Inc. | $14,535 |
|---|---|
| Philips North America LLC | $1,281 |
| Bayer HealthCare Pharmaceuticals Inc. | $246 |
| E.r. Squibb & Sons, L.l.c. | $151 |
| Shockwave Medical, Inc | $142 |
| Abiomed | $102 |
| Novartis Pharmaceuticals Corporation | $36.11 |
| Pfizer Inc. | $20.69 |
| Compensation for services other than consulting (speaking, faculty) | $13,769 |
|---|---|
| Travel and Lodging | $1,454 |
| Food and Beverage | $1,301 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,800 |
| Amgen Inc. Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,800 |
| Amgen Inc. Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,800 |
| Amgen Inc. Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,800 |
| Philips North America LLC Jan 4, 2025 | Travel and Lodging Coronary Other · Medical Device · travel to Atlanta, GA | $774 |
| Amgen Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $701 |
| Amgen Inc. Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $467 |
| Amgen Inc. Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $467 |
| Amgen Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $467 |
| Amgen Inc. Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $467 |
All 15 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,800 |
| Amgen Inc. Aug 19, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $467 |
| Amgen Inc. Jun 30, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to Grand Blanc, MI | $104 |
| Amgen Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,800 |
| Amgen Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $467 |
| Amgen Inc. Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,800 |
| Amgen Inc. Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $467 |
| Amgen Inc. Mar 25, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to PORT AUSTIN, MI | $60.90 |
| Amgen Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $701 |
| Amgen Inc. Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,800 |
| Amgen Inc. Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $467 |
| Amgen Inc. Feb 21, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to FLINT, MI | $91.00 |
| Philips North America LLC Feb 1, 2025 | Travel and Lodging Coronary Other · Medical Device · travel to San Diego, CA | $404 |
| Philips North America LLC Jan 9, 2025 | Travel and Lodging Coronary Other · Medical Device · travel to Arlington, VA | $20.37 |
| Philips North America LLC Jan 4, 2025 | Travel and Lodging Coronary Other · Medical Device · travel to Atlanta, GA | $774 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $4,550 in research payments for these studies, mostly to the institutions running them.
- Dapagliflozin in Acute Decompensated Heart Failure
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.